Brainfulness

Founded by two scientists, one with a strong background in medicine, and the other in performance education, Brainfulness introduces a new paradigm in Neurobiology based on the idea of “Repetitive Triggered Somatosensory Discrimination”. Our device and software treat anxiety and depression without side effects, without the use of medication, electric shocks, or magnetic fields, and without any need for expensive doctors or hospitalization. In 2015, we have conducted a successful open-pilot clinical study with positive results. Participants in the trial included 30 chronic patients who were resistant to any previous treatments. Brainfulness has 4 approved patents in Germany, Japan, US, and Israel, and has received approval to use the device on humans from the Israel Ministry of Health as well as approval from the Helsinki Committee.